Type to search

NEJM Publishes Phase 2b Clinical Trial Results Demonstrating Efficacy of Novavax COVID-19 Vaccine Against the B.1.351 Variant | Pharmtech Focus
Novavax Initiates Pediatric Expansion for Phase 3 Clinical Trial of COVID-19 Vaccine | Pharmtech Focus
Cumulus Neuroscience Announces £6 million Funding Round Led by the Dementia Discovery Fund and joined by LifeArc and UK Future Fund | Pharmtech Focus